Personalizing the Selection of Systemic Therapies for Moderate-to-Severe Atopic Dermatitis

FACULTY

Lisa Arkin, MD
Associate Professor and Director of Pediatric Dermatology
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

PROGRAM OVERVIEW

In this podcast episode, we will review how to monitor a patient’s response to therapy for moderate-to-severe atopic dermatitis and how to coordinate care across specialties in this pediatric patient population.

TARGET AUDIENCE

This activity is intended for dermatologists, pediatric dermatologists, allergists, immunologists, and other health care professionals involved in managing pediatric and adult patients with moderate-to-severe atopic dermatitis.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Assess patients with atopic dermatitis (AD) over time for uncontrolled symptoms, treatment response, and health-related quality of life

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or

other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Dave Chatman, Medical Services for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
• Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:

1. Read the CME information and faculty disclosures.
2. Complete the pre-test before listening.
3. Participate in the activity by listening to the podcast.
4. Complete online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]

Please listen to the podcast below:

FACULTY

Lisa Arkin, MD
Associate Professor and Director of Pediatric Dermatology
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

PROGRAM OVERVIEW

In this podcast episode, we will review how to monitor a patient’s response to therapy for moderate-to-severe atopic dermatitis and how to coordinate care across specialties in this pediatric patient population.

TARGET AUDIENCE

This activity is intended for dermatologists, pediatric dermatologists, allergists, immunologists, and other health care professionals involved in managing pediatric and adult patients with moderate-to-severe atopic dermatitis.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Individualize the long-term treatment of moderate-to-severe atopic dermatitis (AD) to prevent disease exacerbations, manage comorbidities, minimize adverse events, and improve quality of life
• Compare the efficacy and safety of systemic therapies for AD to aid in the selection of treatments for patients with moderate-to-severe disease

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they partner have with ineligible companies related to the content of this CME activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Dave Chatman, Medical Services for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
• Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:

1. Read the CME information and faculty disclosures.
2. Complete the pre-test before listening.
3. Participate in the activity by listening to the podcast.
4. Complete online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]

Please listen to the podcast below:

FACULTY

Jonathan I. Silverberg, MD, PhD, MPH (Program Chair)
Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

PROGRAM OVERVIEW

In this podcast episode, we will review how to assess the severity of a patient’s atopic dermatitis, its impact on their daily activities, and how to coordinate care when needed with other specialists.

TARGET AUDIENCE

This activity is intended for dermatologists, pediatric dermatologists, allergists, immunologists, and other health care professionals involved in managing pediatric and adult patients with moderate-to-severe atopic dermatitis.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Assess patients with atopic dermatitis (AD) over time for uncontrolled symptoms, treatment response, and health-related quality of life

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Dave Chatman, Medical Services for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
• Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:

• Read the CME information and faculty disclosures.
• Complete the pre-test before listening.
• Participate in the activity by listening to the podcast.
• Complete online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]

Please listen to the podcast below:

FACULTY

Jonathan I. Silverberg, MD, PhD, MPH (Program Chair)
Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

PROGRAM OVERVIEW

In this podcast episode, we will review how to assess the severity of a patient’s atopic dermatitis, its impact on their daily activities, and how to coordinate care when needed with other specialists.

TARGET AUDIENCE

This activity is intended for dermatologists, pediatric dermatologists, allergists, immunologists, and other health care professionals involved in managing pediatric and adult patients with moderate-to-severe atopic dermatitis.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Compare the efficacy and safety of systemic therapies for atopic dermatitis (AD) to aid in the selection of treatments for patients with moderate-to-severe disease

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Dave Chatman, Medical Services for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
• Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:

1. Read the CME information and faculty disclosures.
2. Complete the pre-test before listening.
3. Participate in the activity by listening to the podcast.
4. Complete online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]

Please listen to the podcast below:

FACULTY

Hyee Jin Ahn, MMS, PA-C
Dermatology Physician Assistant
UW Health
Madison, WI

PROGRAM OVERVIEW

In this episode, we will review the management of patients with moderate-to-severe atopic dermatitis; typical regimens, side effects to be aware of, and how to treat acute flares.

TARGET AUDIENCE

This activity is intended for dermatologists, pediatric dermatologists, allergists, immunologists, and other health care professionals involved in managing pediatric and adult patients with moderate-to-severe atopic dermatitis.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Compare the efficacy and safety of systemic therapies for atopic dermatitis (AD) to aid in the selection of treatments for patients with moderate-to-severe disease

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Dave Chatman, Medical Services for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
• Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:

1. Read the CME information and faculty disclosures.
2. Complete the pre-test before listening.
3. Participate in the activity by listening to the podcast.
4. Complete online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]

Please listen to the podcast below:

Guests

Sarah Caldwell
(Mother)
Madison, WI

Evan Caldwell
Madison, WI

PROGRAM OVERVIEW

In this podcast episode we will hear the patient’s and caretaker perspective regarding initial diagnosis and effects of atopic dermatitis on their quality-of-life.

TARGET AUDIENCE

This activity is intended for dermatologists, pediatric dermatologists, allergists, immunologists, and other health care professionals involved in managing pediatric and adult patients with moderate-to-severe atopic dermatitis.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Assess patients with atopic dermatitis (AD) over time for uncontrolled symptoms, treatment response, and health-related quality of life

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Dave Chatman, Medical Services for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
• Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:

1. Read the CME information and faculty disclosures.
2. Complete the pre-test before listening.
3. Participate in the activity by listening to the podcast.
4. Complete online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]

Please listen to the podcast below: